Intraoperative and postoperative infusion of dexmedetomidine combined with intravenous butorphanol patient-controlled analgesia after total hysterectomy under laparoscopy

dexmedetomidine combined with butorphanol patient-controlled analgesia after total hysterectomy under laparoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800015675

Enrollment

Unknown

Registered

2018-04-14

Start date

2018-04-17

Completion date

Unknown

Last updated

2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Control group:patient-controlled analgesia

Dex group:Dex+butorphanol PCIA

Eligibility

Sex/Gender

Female

Age

38 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged 38 to 65 yr, American Society of Anesthesiologists (ASA) I or II, undergoing total hysterectomy under laparoscopy with general anaesthesia.

Exclusion criteria

Exclusion criteria: ASA at least III, obesity (BMI>30), opioid addiction, sedative–hypnotic drug(s), uncontrolled hypertension, severe heart disease, conduction abnormality, neuropsychiatric diseases, alcohol abuse, allergy to either butorphanol or dexmedetomidine.

Design outcomes

Primary

Measure	Time frame
analgesic effect;	—

Secondary

Measure	Time frame
adverse effects;	—

Countries

China

Contacts

Public ContactJiahai Ma

Yuhuangding Hospital of Qingdao University

mjh-214@163.com+86 13656456186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026